Literature DB >> 18603553

Enumeration of cytomegalovirus-specific interferongamma CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection.

Carlos Solano, Isana Benet, María A Clari, José Nieto, Rafael de la Cámara, Javier López, Juan C Hernández-Boluda, María J Remigia, Isidro Jarque, María L Calabuig, Ana Garcia-Noblejas, Juan Alberola, Amparo Tamarit, Concepción Gimeno, David Navarro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18603553     DOI： 10.3324/haematol.12880

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

1.  The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.

Authors:  E Albert; C Solano; E Giménez; D Focosi; A Pérez; L Macera; J L Piñana; J C H Boluda; F Maggi; D Navarro
Journal:  Bone Marrow Transplant       Date:  2017-10-30       Impact factor: 5.483

2.  Post transplant CMV-specific T-cell immune reconstitution in the absence of global T-cell immunity is associated with a high risk of subsequent virus reactivation.

Authors:  S-K Tey; M P Davenport; G R Hill; G A Kennedy; S T Durrant; R Khanna; D Cromer
Journal:  Bone Marrow Transplant       Date:  2014-11-17       Impact factor: 5.483

3.  Reply to Giménez et al.

Authors:  Lynn El Haddad; Ella Ariza-Heredia; Roy F Chemaly
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

4.  Performance of the QuantiFERON-cytomegalovirus (CMV) assay for detection and estimation of the magnitude and functionality of the CMV-specific gamma interferon-producing CD8(+) T-cell response in allogeneic stem cell transplant recipients.

Authors:  María Ángeles Clari; Beatriz Muñoz-Cobo; Carlos Solano; Isabel Benet; Elisa Costa; María José Remigia; Dayana Bravo; Paula Amat; David Navarro
Journal:  Clin Vaccine Immunol       Date:  2012-02-29

5.  Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantation.

Authors:  T W H Flinsenberg; L Spel; M Jansen; D Koning; C de Haar; M Plantinga; R Scholman; M M van Loenen; S Nierkens; L Boon; D van Baarle; M H M Heemskerk; J J Boelens; M Boes
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

6.  Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant Recipients.

Authors:  David Navarro; Paula Amat; Rafael de la Cámara; Javier López; Lourdes Vázquez; David Serrano; José Nieto; Monserrat Rovira; José Luis Piñana; Estela Giménez; Carlos Solano
Journal:  Open Forum Infect Dis       Date:  2016-05-18       Impact factor: 3.835

Review 7.  The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People.

Authors:  Eleanor Y Lim; Sarah E Jackson; Mark R Wills
Journal:  Front Cell Infect Microbiol       Date:  2020-05-19       Impact factor: 5.293

8.  T cell-mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19.

Authors:  Mario Fernández-Ruiz; Beatriz Olea; Patricia Almendro-Vázquez; Estela Giménez; Alberto Marcacuzco; Rafael San Juan; Iago Justo; Jorge Calvo-Pulido; Álvaro García-Sesma; Alejandro Manrique; Oscar Caso; Félix Cambra; Paloma Talayero; Francisco López-Medrano; María José Remigia; Tamara Ruiz-Merlo; Patricia Parra; Estela Paz-Artal; Carlos Jiménez; Carmelo Loinaz; David Navarro; Rocío Laguna-Goya; José M Aguado
Journal:  Am J Transplant       Date:  2021-06-25       Impact factor: 9.369

9.  Impaired polyfunctionality of CD8+ T cells in severe sepsis patients with human cytomegalovirus reactivation.

Authors:  Young Joon Choi; Sun Bean Kim; Jong Hoon Kim; Su-Hyung Park; Moo Suk Park; June Myung Kim; Sang Hoon Han; Eui-Cheol Shin
Journal:  Exp Mol Med       Date:  2017-09-29       Impact factor: 8.718

10.  SARS-CoV-2-reactive interferon-γ-producing CD8+ T cells in patients hospitalized with coronavirus disease 2019.

Authors:  Estela Giménez; Eliseo Albert; Ignacio Torres; María José Remigia; María Jesús Alcaraz; María José Galindo; María Luisa Blasco; Carlos Solano; María José Forner; Josep Redón; Jaime Signes-Costa; David Navarro
Journal:  J Med Virol       Date:  2020-07-02       Impact factor: 20.693
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.